For virologically suppressed adult patients with HIV-1. See Full Indication.
JULUCA | Innovative Pairing
An Innovative Pairing With Dolutegravir
The pairing of dolutegravir and rilpivirine inhibits the viral life cycle at 2 separate sites,
like 3-drug regimens
You may also be interested in
MILESTONES IN THE TREATMENT OF HIV-1
CLINICAL TRIALS
RISKS & SIDE EFFECTS
DGRWCNT210011